MK-2866 (Ostarine) – Solution, 30mg x 30mL

MK-2866 (Ostarine) – Solution, 30mg x 30mL

$50.00

30mg per mL, 900mg/30mL total; includes 1mL pipette

Bulk Pricing
1 2-4 5-9 10-24 25-49 50+
$50.00 $45.00 $40.00 $35.00 $30.00 $25.00
SKU: ostarine-solution Categories: , Tags: , , ,
000

Read the Specification Before Buying:

Application Selective Androgen Receptor Modulator
CAS 841205-47-8
Molar Mass 389.33 g/mol
Chemical Formula C19H14F3N3O3
Chemical Name ((2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)
Synonyms Ostarine, Enobosarm, GTx-024, MK-2866
Storage Room temperature
Solubility PEG, Ethanol
Organoleptic Profile Clear liquid
Physical Form Solution in PEG, Ethanol
Reports HNMR, HPLC
Terms The products we offer are intended for laboratory research use only.
Please familiarize yourself with our Terms & Conditions prior to ordering.

Literature

  1. Mohler ML, Bohl CE, Jones A, et al. (June 2009). “Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit”. J. Med. Chem. 52 (12): 3597–617. doi:10.1021/jm900280m.PMID 19432422.
  2. WO application 2008127717, James T. Dalton and Duane D. Miller, “Selective Androgen Receptor Modulators for Treating Diabetes”, published Oct 23, 2008, assigned to University of Tennessee Research Foundation, James T. Dalton, and Duane D. Miller
  3. Zhang X, Lanter JC, Sui Z (September 2009). “Recent advances in the development of selective androgen receptor modulators”. Expert Opin Ther Pat 19 (9): 1239–58. doi:10.1517/13543770902994397. PMID 19505196.
  4. Jones A, Chen J, Hwang DJ, Miller DD, Dalton JT (January 2009). “Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception”.Endocrinology 150 (1): 385–95. doi:10.1210/en.2008-0674. PMC 2630904. PMID 18772237.
  5. Thevis M, Kohler M, Schlörer N, Kamber M, Kühn A, Linscheid MW, Schänzer W. Mass spectrometry of hydantoin-derived selective androgen receptor modulators. Journal of Mass Spectrometry. 2008 May;43(5):639-50. PMID 18095383
  6. Thevis M, Kohler M, Thomas A, Maurer J, Schlörer N, Kamber M, Schänzer W. Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS. Analytical and Bioanalytical Chemistry. 2008 May;391(1):251-61. PMID 18270691